Ellodi Pharmaceuticals Email Format
Pharmaceutical ManufacturingPennsylvania, United States11-50 Employees
Ellodi Pharmaceuticals is a gastroenterology-focused specialty pharmaceutical company, founded in 2020 and based in Blue Bell, Pennsylvania. Its work centers on eosinophilic esophagitis, a rare chronic allergic inflammatory condition, with the aim of developing a first-line therapy where none exists today. The company builds on the groundwork from Adare Pharmaceuticals, including APT-1011, which is in Phase 3 clinical development. Ellodi assembles a team with extensive experience in bringing gastrointestinal and rare-disease therapies from development toward potential commercialization. The organization emphasizes considering patients and caregivers in its decision making as it pursues therapies intended to improve the lives of those affected by EoE. Positioned in the pharmaceutical manufacturing sector, Ellodi seeks to accelerate the clinical development of treatments for EoE.